Effect of TECAR on Supraspinatus Tendon Thickness in Supraspinatus Tendinitis

NCT07794033 | Not Yet Recruiting

• 1 other identifier: P.T.REC/012/006619
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Is the TECAR therapy effective on supraspinatus tendon thickness, sub acromial space, pain intensity , shoulder range of motion, muscle strength ( supraspinatus and middle fiber of deltoid) and functional disabilities in patients with supraspinatus tendinitis?

Conditions

Supraspinatus Tendonitis

Keywords

TECAR; supraspinatus tendonitis; sub acromial space

Outcome Measures

Primary Outcomes (2)

• tendon thickness of supraspinatus muscle

  tendon thickness of supraspinatus muscle will be measured by ultrasonography

  up to four weeks

• Sub acromial space

  Sub acromial space will be assessed using Ultrasonography.

  up to four weeks

Secondary Outcomes (4)

• pain intensity

  up to four weeks

• Shoulder Range of motion

  up to four weeks

• Muscle strength

  up to four weeks

• Shoulder functional disability

  up to four weeks

Study Arms (2)

TECAR therapy

EXPERIMENTAL

25 Patients will receive TECAR therapy and conventional physiotherapy three times per week for four weeks

Other: TECAR therapy; Other: conventional physiotherapy

conventional physiotherapy

ACTIVE COMPARATOR

25 patients will receive conventional physiotherapy only three times per week for four weeks

Other: conventional physiotherapy

Interventions

TECAR therapy OTHER

Patients will be in a comfortable side-lying with treated shoulder uppermost and clean the area over the affected shoulder, apply coupling medium and then apply Capacitive mode to shoulder muscles for 10 minutes and Resistive mode for another 10 minutes.

TECAR therapy

conventional physiotherapy OTHER

Patients will receive conventional physiotherapy (range of motion exercises, stretching exercises, strengthening exercises, and scapular stabilization exercises).

TECAR therapy; conventional physiotherapy

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Fifty patients with chronic supraspinatus tendinitis on the dominant side.
• Patients with age range from 18 to 65 years old from both genders.
• Patients reporting positive empty can test.
• patients reporting pain with resisted isometric abduction.
• Patients experiencing shoulder pain for at least 4 weeks.
• patients reporting pain with active shoulder elevation in the scapular plane.

You may not qualify if:

• Patients with shoulder surgery or trauma in the past 6 months will be excluded.
• Patients with full-thickness rotator cuff tears, fractures, or severe osteoarthritis will be excluded.
• Patients with systemic diseases affecting tendon healing (e.g., uncontrolled diabetes, rheumatoid arthritis) will be excluded.
• Patients who were pregnant or breastfeeding will be excluded.
• Patients currently receiving other shoulder therapies that could affect outcomes will be excluded.
• Patients with frozen shoulder will be excluded.
• Patients with glenohumeral or acromioclavicular arthritis will be excluded.
• Patients with an implanted pacemaker will be excluded.

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Shireen Mohamed Mahmoud

Giza, 11432, Egypt

Location

Study Officials

• Alshaymaa Sh Abd El-Azeim, PHD

  Assistant professor

  STUDY DIRECTOR

Central Study Contacts

Shireen M Mahmoud, Demonstrator

CONTACT

01121768657; shireenmohamed155@icloud.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: demonstrator of physical therapy

Study Record Dates

• First Submitted: August 26, 2026
• First Posted: August 31, 2026
• Study Start: September 10, 2026
• Primary Completion (Estimated): April 10, 2027
• Study Completion (Estimated): April 10, 2027
• Last Updated: September 1, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: one year
• Access Criteria: the criteria will be accessed by the publication of trials in international journal

Locations

EG (1)